Skip to main content
. 2021 Dec 2;12:772941. doi: 10.3389/fimmu.2021.772941

Figure 4.

Figure 4

The symptoms of dry skin and reduction in TSLP levels were less pronounced in TRPV4-deficient mice following AEW treatment. (A) The skin of Trpv4 -/- mice appeared less dry following AEW treatment. (B) On day 5 after treatment with AEW, the skin lesion scores gradually decreased in the following order: Trpv4+/+ (n = 6) > Trpv4+/- (n = 6) > Trpv4 -/- (n = 6). (C) Representative H&E-stained images of the skin tissues of Trpv4+/+ and Trpv4 -/- mice following AEW treatment. (D) The epidermal thickness significantly decreased in both AEW-treated Trpv4+/- mice (n = 6) and Trpv4 -/- mice (n = 6). (E) The values of TEWL significantly reduced in the AEW-treated Trpv4+/- mice (n = 6) and Trpv4 -/- mice (n = 6). (F) The spontaneous scratching bouts were reduced in AEW-treated Trpv4+/- mice (n = 6) and Trpv4 -/- mice (n = 6). (G) The serum levels of TSLP significantly decreased in the AEW-treated Trpv4+/- mice (n = 6) and Trpv4 -/- mice (n = 6). (H) The levels of TSLP in the skin significantly reduced in the AEW-treated Trpv4 -/- mice (n = 6), compared to those of the control (n = 6). *p < 0.05, **p < 0.01, ***p < 0.001.